We transform the knowledge of the Bio&Tech sector into high-impact investments.
Bio&Tech Smart Capital is the first Galician vertical investment fund specialized in the biotech, med tech, health tech, diagnostics and digital sectors oriented to life sciences.
It is integrated by professionals with long experience in Venture Capital, researchers, and entrepreneurs with a deep knowledge of the sector. This allows us to discover projects with differentiating technologies, high potential, and exceptional value, to accelerate them with our investment and extensive experience in entrepreneurship and a network of allies with access to national and international markets.
Galicia offers access to high quality, solid and low risk startup projects, thanks to a consolidated innovative biotech ecosystem backed by the leadership of university research, innovation laboratories and institutional support.
Bio&Tech Smart Capital will stimulate and strengthen the creation of productive fabric, supporting seed stage entrepreneurs and Series A projects, with a willingness to accompany them. This will allow investors to access high returns.
Our fund has 50 million euros and will invest in 30-40 companies, 50% of them located in Galicia.
We promote sustainable growth in the Bio&Tech sector.
Bio&Tech Smart Capital is the alliance of researchers and entrepreneurs with Venture Capital management professionals to transfer scientific knowledge to society, with the aim of transform projects into solid and profitable companies of spin off and startups emerging from universities, research laboratories, innovation and institutions.
Our strengths
EXHAUSTIVE knowledge of investment sectors.
EXPERIENCE and knowledge in detail of what a project requires.
SUPPORT in strategy, management and access to international markets.
PROJECTION & ACCESS to a network of partners in the Americas, Asia and Europe.
Four reasons to invest in Bio&Tech Smart Capital:
√ Experienced entrepreneurs and investors with a track record of success.
√ Professionals connected to the Bio&Tech ecosystem and access to global transactions.
√ Investment in Projects with reduced risk.
√ Access to global multipliers.
A good team is essential for success
Ours is made up of exceptional, multidisciplinary, multicultural professionals of diverse nationalities. They have more than 200 years of business experience and have achieved high value investments and high multipliers.
SANTI DOMÍNGUEZ
General Partner
Life Science & Digital
Expert Entrepreneur
PABLO ÁLVAREZ
General Partner
Life Science Expert
TOMÁS PÉREZ
General Partner CEO
DANIEL PRIETO
General Partner
Operational & Industry 4.0 Entrepreneur
LUCÍA CASTRO DIAZ
General Partner
Digital & Biobased
ELENA RIVAS
General Partner
Life Science Expert Entrepreneur
VICENTE ESPERT
General Partner CFO
JORGE PEREIRA
General Partner
Life Science & Digital Finance
ÁLVARO JIMÉNEZ
General Partner
Life Science Expert
ANI CHAHAL
General Partner
Life Science Expert
ISAAC CHOCRON
General Partner – Israel Startup Nation
OurCrowd Director
Investment criteria
Bio&Tech Smart Capital focuses its activity on:
● Digital technologies applied to life sciences (focus on automation and data science).
● Biotechnology.
● Diagnostics and medical devices.
● Sustainability.
Selected based on a combination of: social impact, potential profitability and the team’s experience and knowledge of the sector.
Diversification: no sector will represent more than 50% of the invested capital.
Return target: multiply the capital invested in 7 years
Responsable investment
Bio&Tech Smart Capital has the vocation to discover projects with differentiating technologies, high potential and exceptional value and accelerate them not only with our investment, but with our extensive experience in entrepreneurship and management in the sector, to which we add our network of national and international contacts and the ability to access global markets.
We do this with the vision of transforming the knowledge generated by the BioTech ecosystem into high value-added companies through our experience as researchers, entrepreneurs and investors, in accordance with ESG and sustainability criteria.
We work to weave alliances that transform our lives.
Promoting open innovation
BEST START-UPS
Exclusive dedication with innovation and their Business Development.
BETTER BUSINESS
Competitiveness: Value Creation is the Shared by all and in increases.
IMPROVING THE ECOSYSTEM
Research results to innovate and generate value.
BETTER COMPANIES
Tractor companies: the benefit of external talent .
SPEED AND VALUE
Stakeholders interact each other to develop businesses and create shared value.
BETTER SME´S
Accesible innovation: SME`s can access latest advances innovation.
Unique Investment Position
Bio&Tech Smart Capital offers a unique positioning for your investment:
● Highly developed projects in seed stage, thanks to strong institutional and university support. Validated product, structured team and initial revenues. Therefore, access to reduced risk investments.
● Connection with the Galician and Spanish startup ecosystem and access s to global deal flow (California, Seattle, Boston, New York, London, Germany, Switzerland, Ireland, Middle East and Israel).
● • The European approach combined with a global network makes it possible to invest in attractive European multipliers and obtain global multipliers (USA).
● A team with 200 years of experience and a track record of success as entrepreneurs and investors. Creation of 3 Life Sciences startups with +200 million euros of added value and an investment of less than €10 million.
● Extensive experience in company management, valuation and monitoring of investments.
- Sectors
Bio&Tech Smart Capital focuses its interest in sectors with potential social impact, profitability expectations and the experience and knowledge of our team in this area of economic activity:
● Digital technologies applied to life sciences (focus on automation and data science).
● Biotechnology.
● Diagnostics and medical devices.
● Sustainability.
- Projects
● 25-30 projects.
● 15-20 projects en seed capital. Tickets from 200,000 to 400,000 euros.
● 10-12 projects in Series A. Tickets from 2 to 5 million euros (several phases depending on milestones achieved).
● 50% of Investment in projects in Galicia.
● 50% in national / international projects.
